Key statistics
On Monday, Arcellx Inc (ACLX:NSQ) closed at 114.05, -0.18% below its 52-week high of 114.26, set on Feb 23, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 113.83 |
|---|---|
| High | 114.15 |
| Low | 113.77 |
| Bid | 113.81 |
| Offer | 114.25 |
| Previous close | 113.79 |
| Average volume | 7.99m |
|---|---|
| Shares outstanding | 58.48m |
| Free float | 49.24m |
| P/E (TTM) | -- |
| Market cap | 6.65bn USD |
| EPS (TTM) | -4.06 USD |
Data delayed at least 15 minutes, as of Mar 02 2026 21:00 GMT.
More ▼
- Gilead Sciences to Acquire Arcellx to Maximize Long-Term Potential of Anito-cel
- Gilead Sciences to Acquire Arcellx to Maximize Long-term Potential of Anito-cel
- Arcellx Announces Late-Breaking Presentation at TANDEM Demonstrating Unique, High Target-Specificity of anito-cel’s D-Domain Binder
- Arcellx to Advance the Conversation on Its Platform and the Importance of Early CAR T Access for Patients with Multiple Myeloma During the 2026 Tandem Meetings
- Arcellx Announces New Positive Data for Its iMMagine-1 Study in Patients with Relapsed and/or Refractory Multiple Myeloma
More ▼
